Work

Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon ‐ HP trial

Year: 2024

Type: article

Abstract: The efficacy of vonoprazan-based dual and triple therapy vs. lansoprazole-based triple therapy in the treatment of H. pylori infection was largely consistent regardless of age, sex, race, ethnicity, BMI, alcohol intake, smoking status, and study drug compliance.

Source: JGH Open

DOI: 10.1002/jgh3.70044

Authors: William D Chey, Francis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke, Barbara Hunt, Colin W Howden

Institutions: University of Michigan, Michigan Medicine, Université de Bordeaux, Inserm, BoRdeaux Institute of onCology, Yale University, VA Connecticut Healthcare System, Phathom Pharmaceuticals, Inc. (United States), University of Tennessee Health Science Center

Language: English

Topic: Helicobacter pylori-related gastroenterology studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,310

Funders: National Institutes of Health, National Center for Advancing Translational Sciences

Awards: G1044130170, Yale Clinical and Translational Science Award

OpenAlex ID: W4404411106

FWCI: 0.38

Cites: 8

Cited by: 1

Related to: 10